Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7339049 | 0.98 | MAPT (0.56) | CYP3A4MAPTKDM4EIDO1THRB | |
| SCHEMBL1792873 | 0.87 | IDO1 (0.60) | CYP3A4MAPTKDM4EIDO1THRB | |
| SCHEMBL25962733 | 0.86 | CYP3A4 (0.48) | CYP3A4MAPTKDM4EIDO1THRB | |
| Hydrochloric Acid SCHEMBL7340226 | 0.84 | MAPT (0.62) | CYP3A4MAPTKDM4EIDO1THRB | |
| SCHEMBL2893366 | 0.81 | MEN1 (0.50) | CYP3A4MAPTKDM4EIDO1THRB | |
| Hydrochloric Acid SCHEMBL11560498 | 0.79 | MAPT (0.52) | CYP3A4MAPTKDM4EIDO1THRB | |
| SCHEMBL11129280 | 0.78 | HDAC3 (0.51) | CYP3A4MAPTKDM4EMEN1KMT2A | |
| SCHEMBL2146 | 0.77 | MEN1 (0.64) | CYP3A4MAPTKDM4EIDO1THRB | |
| Benzene SCHEMBL7471176 | 0.77 | MEN1 (0.64) | CYP3A4MAPTKDM4EIDO1THRB | |
| SCHEMBL3501486 | 0.77 | CYP3A4 (0.61) | CYP3A4MAPTKDM4EIDO1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1037633-B1 | ANTIVIRAL COMPOUNDS | IAF BIOCHEM INT (CA) | 2003-09-10 | — | — | EP | claimed |
| CN-1283995-A | Antiviral compounds | IAF BIOCHEM INT (CA) | 2001-02-14 | — | — | CN | claimed |
| EP-1037633-A1 | ANTIVIRAL COMPOUNDS | BIOCHEM PHARMA INC (CA) | 2000-09-27 | — | — | EP | claimed |
| WO-1999029318-A1 | ANTIVIRAL COMPOUNDS | BIOCHEM PHARMA INC. (CA) | 1999-06-17 | — | — | WO | claimed |
| US-20200290990-A1 | METHODS FOR TREATING PROTOZOAN INFECTIONS | NEOCULI PTY LTD (AU) | 2020-09-17 | — | — | US | disclosed |
| CN-105267066-B | Method for treating hair and kit therefor | 知识产权全资有限公司 | 2019-06-11 | — | — | CN | disclosed |
| US-6399631-B1 | 3-AMIDO OR 3-SULFONAMIDO; EATING DISORDERS IN HUMANS, DOGS AND CATS | PFIZER INC. | 2002-06-04 | — | — | US | disclosed |
| CN-1069643-C | Naphthyridine derivatives and their analogues inhibiting cytomegalovirus | IAF BIOCHEM INT (CA) | 2001-08-15 | — | — | CN | disclosed |
| CN-1283995-A | Antiviral compounds | IAF BIOCHEM INT (CA) | 2001-02-14 | — | — | CN | disclosed |
| EP-1037633-A1 | ANTIVIRAL COMPOUNDS | BIOCHEM PHARMA INC (CA) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999029318-A1 | ANTIVIRAL COMPOUNDS | BIOCHEM PHARMA INC. (CA) | 1999-06-17 | — | — | WO | disclosed |
| CN-1218473-A | Naphthyridine derivatives and their analogues inhibiting cytomegalovirus | IAF BIOCHEM INT (CA) | 1999-06-02 | — | — | CN | disclosed |
| US-3997544-A | Plant growth regulant carbamoylphosphonates | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-12-14 | — | — | US | disclosed |
| US-3981870-A | Plant growth regulant carbamoylphosphonates | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
| US-3975464-A | PLANT GROWTH REGULATOR | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 1976-08-17 | — | — | US | disclosed |
| US-3952074-A | PLANT GROWTH REGULATOR | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200290990-A1 | METHODS FOR TREATING PROTOZOAN INFECTIONS | DPM1, ABCB11, PIGS | CYP3A4 720/4885MAPT 3694/4885KDM4E 3521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.